Location: Home
  • search
  • go
  • Relate News
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
  • 5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
  • 5/14/2025Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
  • 5/12/2025AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...
  • 5/12/2025CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...
  • 5/12/2025CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...
  • 5/12/2025China Biopharma Financing Drops in April 2025, Signals Investor Cautio...
  • 5/12/2025EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...
  • 5/12/2025Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...
  • 5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
  • 5/12/2025Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...
  • 5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
  • 5/10/2025~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
  • 5/10/2025China's BMI Fund Reports Big Surplus in Q1/2025
  • 5/10/2025Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
  • 5/10/2025AstraZeneca Launches $475M Small Molecule Drug Plant Project in Wuxi t...
  • 5/10/2025Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
  • 5/10/2025China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
  • 5/10/2025Recent Executive Moves
  • 5/9/202583 Listed Chinese Pharma Firms Top 70% Margins in 2024
  • 5/9/2025China Grants Tariff Exemptions on Select Pharmaceuticals, Microchips, ...
  • 5/9/2025Chinese Biotechs Turn to Switzerland as U.S. Partnerships Waver
  • 5/9/2025China Still Go-To Source for New Drugs Despite Tariff Minefield (BioSp...
  • 5/8/2025Redefining Translational Research and China's Impact on US Drug Develo...
  • 5/8/2025Dementia Cases Surge in China at an Unprecedented Rate
  • Page:39/803 Total number of articles:24081: [First][<<] [37] [38] [39] [40] [41] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group